The bone-remodeling transient: Implications for the interpretation of clinical studies of bone mass change
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
A computer simulation of the bone-remodeling transient is described, in which the focus is explicitly on changes in clinically measurable bone mass (or density). Based upon quantitative remodeling data accumulated by histomorphometry and calcium tracer kinetics, the simulation shows that much of the apparent gain in bone produced by several agents currently employed to treat osteoporosis can be explained as a remodeling transient rather than as a fundamental alteration of remodeling balance. Even gains as large as 30% or more can be produced by nothing more than the remodeling transient under certain plausible combinations of basal remodeling rate, remodeling period, and degree of bone loss. The simulation further highlights the importance, in evaluating bone-active agents, of separating the response across the first remodeling period from bone changes that may ensue thereafter.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the relatively short study durations (i.e. 3-6 months; bone remodeling typically takes a minimum of six months (45)) and lack of sensitivity in whole body BMD to change could also explain these findings.”
From G LP1Ra ‐based therapies and DXA ‐acquired musculoskeletal health outcomes: a focused meta‐analysis of placebo‐controlled trials (2025) · cites this paper as [45]
Citations
Cites
Bone histomorphometry : techniques and interpretation
Recker, R. R. (1983) · CRC Press eBooks · Cited by 1,158
Calcium Supplementation and Increases in Bone Mineral Density in Children
Johnston, C. C., Miller, J. Z., Slemenda, C. W., Reister, T. K., Hui, S., Christian, J. C., & Peacock, M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270204 · Cited by 1,069
A Controlled Trial of the Effect of Calcium Supplementation on Bone Density in Postmenopausal Women
Dawson-Hughes, B., Dallal, G. E., Krall, E. A., Sadowski, L., Sahyoun, N., & Tannenbaum, S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009273231305 · Cited by 947
Effect of Calcium Supplementation on Bone Loss in Postmenopausal Women
Reid, I. R., Ames, R. W., Evans, M. C., Gamble, G. D., & Sharpe, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280702 · Cited by 512
Calcium Supplementation and Bone Mineral Density in Adolescent Girls
Lloyd, T. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510070063037 · Cited by 496
Menopausal changes in bone remodeling.
Heaney, R. P., Recker, R. R., & Saville, P. D. (1978) · PubMed · Cited by 471
Self-citationBone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
Civitelli, R., Gonnelli, S., Zacchei, F., Bigazzi, S., Vattimo, A., Avioli, L. V., & Gennari, C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113725 · Cited by 358
Osteoporosis: Etiology, Diagnosis, and Management
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-3-259_4 · Cited by 354
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
Favus, M. J., & Slovik, D. M. (1994) · The Endocrinologist · doi:10.1097/00019616-199403000-00012 · Cited by 321
Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females
Dr. Recker, R. R., Kimmel, D. B., Parfitt, M. A., Davies, M. K., Keshawarz, N., & Hinders, S. (1988) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650030203 · Cited by 277
Research works printed but not linked: 6
- Frost, 1973, Bone Remodeling and its Relationship to Metabolic Bone Disease
- Clinical Aspects of Metabolic Bone Disease, 124
- Parfitt, 1980, Morphologic basis of bone mineral measurements: Transient and steady state effects of treatment in osteoporosis, Miner Electrolyte Metab, 4, 273
- Thomsen, 1993, Computer simulation of multiple remodeling events in human cancellous bone, J Bone Miner Res, 8, S250
- Slemenda, 1993, Bone growth in children following the cessation of calcium supplementation, J Bone Miner Res, 8, S154
- Recker, 1993, Transmenopausal skeletal changes: Trabecular vs. cortico-endosteal surfaces, J Bone Miner Res, 8, S154
Cited by
Items 101–200 of 286
Moyer‐Mileur, L. J., Xie, B., Ball, S. D., & de Pratt, T. (2003) · PubMed · Cited by 54
Calcium and Vitamin D Supplementation in Postmenopausal Women
Aloia, J. F., Dhaliwal, R., Shieh, A., Mikhail, M., Islam, S., & Yeh, J. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2121 · Cited by 53
Frost, H. M. (1998) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740050035 · Cited by 52
“During menopause, global BMU creations, the global remodeling space, and global bone turnover increase [27,28,30,31,36].”
BackgroundCortical Bone Porosity in Rabbit Models of Osteoporosis
Harrison, K. D., Hiebert, B. D., Panahifar, A., Andronowski, J. M., Ashique, A. M., King, G. A., Arnason, T., Swekla, K. J., Pivonka, P., & Cooper, D. M. L. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4124 · Cited by 56
“5 mg/kg for 4 weeks, and the PTH group was dosed by daily subcutaneous injection for 4 weeks with human PTH (1-34) (Alfa Aesar, Ward Hill, MA, USA) at a concentration of 30 μg/kg (dosing period).”
BackgroundMethodFatahi, S., Namazi, N., Larijani, B., & Azadbakht, L. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1431161 · Cited by 51
Roudier, M. P., Corey, E., True, L. D., Hiagno, C. S., Ott, S. M., & Vessella, R. L. (2004) · Cancer treatment and research · doi:10.1007/978-1-4419-9129-4_13 · Cited by 56
Treatment of bone disorders in liver disease
Parés, A., & Guañabens, N. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.007 · Cited by 50
“As a consequence, if resorption exceeds formation there is a negative balance which results in bone loss [55].”
BackgroundBone formation is suppressed with multi-stressor military training
Hughes, J. M., Smith, M. A., Henning, P. C., Scofield, D. E., Spiering, B. A., Staab, J. S., Hydren, J. R., Nindl, B. C., & Matheny, R. W. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-2950-6 · Cited by 51
Baldock, P. A. J., Morris, H. A., Need, A. G., Moore, R. J., & Durbridge, T. C. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.9.1451 · Cited by 50
“In a study of the short-term effects following OVX, the impact of a remodeling transient must be considered.((17))”
BackgroundBeavers, K. M., Beavers, D. P., Martin, S. B., Marsh, A. P., Lyles, M. F., Lenchik, L., Shapses, S. A., & Nicklas, B. J. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx048 · Cited by 50
Bisphosphonates in osteoporosis: recent clinical experience
McClung, M. R. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.2.225 · Cited by 49
“At any given time, a ‘remodelling space’ exists in the skeleton [22].”
BackgroundDibba, B., Prentice, A., Ceesay, M., Mendy, M., Darboe, S., Stirling, D. M., Cole, T. J., & Poskitt, E. M. E. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.3.681 · Cited by 48
New, S. A. (2001) · PubMed · doi:10.1079/pns200085 · Cited by 63
“In this latter study neither bone mineral content nor BMD changes were significant at 18 months, but differences were observed in bone turnover markers, suggesting that the additional Ca suppressed bone remodelling which was followed by a contraction of the bone remodelling space (Heaney, 1994).”
BackgroundVon Thun, N. L., Sukumar, D., Heymsfield, S. B., & Shapses, S. A. (2014) · Menopause · doi:10.1097/gme.0b013e3182a76fd5 · Cited by 46
“remodeling transient that may take up to 2 years to complete.(26) Annual bone loss in weight-stable postmenopausal women reaches up to 1% per year, similar to women in the current trial who regained their weight (loss at the femoral neck,j1.”
Remodeling and skeletal fragility
Heaney, R. P. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1466-4 · Cited by 46
“Furthermore, it ignores the fact that much of the apparent change in BMD with antiresorptives represents a remodeling transient [5].”
BackgroundSelf-citationNielsen, B. D., Potter, G. D., Greene, L. W., Morris, E. L., Murray-Gerzik, M., Smith, W. B., & Martín, M. (1998) · Journal of Equine Veterinary Science · doi:10.1016/s0737-0806(98)80374-2 · Cited by 46
Calcium Metabolism and Correcting Calcium Deficiencies
Emkey, R. D., & Emkey, G. R. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.019 · Cited by 52
“This phenomenon has been referred to as a remodeling transient, the effect of which can last from 3 to 6 months in children and as long as 12 to 18 months in mature adults and the elderly.(173)”
BackgroundGreene, D., & Naughton, G. A. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1317-z · Cited by 49
“It is possible or postulated that increased calcium intake may have a potentiating effect in facilitating daily physical activity to exert a positive influence on bone development at the distal tibia [ 30 ].”
BackgroundThe effect of calcium intake on bone composition and bone resorption in the young growing rat
Creedon, A., & Cashman, K. D. (2001) · British Journal Of Nutrition · doi:10.1079/bjn2001419 · Cited by 45
Calcium and Vitamin D in Osteoporosis
Morgan, S. L. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70189-7 · Cited by 54
Present and future of osteoporosis therapy
Seeman, E., Tsalamandris, C., Bass, S., & Pearce, G. (1995) · Bone · doi:10.1016/8756-3282(95)00203-p · Cited by 47
A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage
Nyman, J. S., Yeh, O. C., Hazelwood, S. J., & Martin, R. B. (2004) · Bone · doi:10.1016/j.bone.2004.03.007 · Cited by 50
“Authors of earlier computa tional studies attributed the asymptotic limit to increases in bone mass following inhibition of bone resorption to the closure and mineralization of a portion of the remodeling space [14,44].”
BackgroundMethodFors, H., Bjarnason, R. G., Wirén, L., Albertsson-Wikland, K. G., Bosaeus, I. G., Bengtsson, B., & Johannsson, G. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01386.x · Cited by 44
“The concept of cyclical GH treatment for a prolonged period of time has been tested in postmenopausal women with osteoporosis with moderate (Holloway et al., 1997) or no effect (Gonnelli et al., 1997).”
Backgroundon behalf of the LEAP Study Investigators, Houghton, K. M., MACDONALD, H. M., McKay, H. A., Guzmán, J., Duffy, C. M., & Tucker, L. B. (2018) · Pediatric Rheumatology · doi:10.1186/s12969-018-0283-4 · Cited by 43
Growth and Bone Mineral Accretion During Puberty in Chinese Girls: A Five-Year Longitudinal Study
Zhu, K., Greenfield, H., Zhang, Q., Du, X., Ma, G., Foo, L. H., Cowell, C. T., & Fraser, D. R. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071006 · Cited by 42
“bone mineral accretion rate, which may partly be explained by bone remodeling transient associated with higher levels of calcium intake.((30)) However, in this cohort of girls, we found that the positive effects of a 2-yr milk supplementation during early puberty on bone mineral accretion had largely disappeared, 3 yr…”
BackgroundErdtsieck, R. J., Pols, H. A. P., Valk, N. K., van Ouwerkerk, B. M., Lamberts, S. W. J., Mulder, P. G. H., & Birkenhäger, J. C. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02920.x · Cited by 45
Mackerras, D., & Lumley, T. (1997) · Bone · doi:10.1016/s8756-3282(97)00181-6 · Cited by 42
Hudson, J. L., Wang, Y., Bergia III, R. E., & Campbell, W. W. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz106 · Cited by 41
“Articles that included bone mineral content within lean mass were included in the analyses because bone mineral content only accounts for ∼5% of total lean mass (50); moreover, bone turnover (remodeling) is very slow, requiring a minimum of 4–6 mo (51).”
BackgroundBala, Y., Chapurlat, R. D., Cheung, A. M., Felsenberg, D., Laroche, M., Morris, E., REEVE, J., Thomas, T., Zanchetta, J., Bock, O., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2101 · Cited by 41
“(12–14) Antiresorptive therapies perturb remodeling by rapidly decreasing the number of cavities excavated by BMUs.”
BackgroundNutrition, genetics and skeletal development.
Matkovic, V. (1996) · Journal of the American College of Nutrition · doi:10.1080/07315724.1996.10718630 · Cited by 40
Exploiting and Bypassing the Bone Remodeling Cycle to Optimize the Treatment of Osteoporosis
Dempster, D. W. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.8.1152 · Cited by 40
“to a computer simulation of bone remodeling.((3)) Using this model, an excellent fit to the observed clinical data was obtained by simulating a 36–38% reduction in remodeling activation frequency, coupled with a positive balance in each remodeling unit of 1.”
MethodBeavers, K. M., Cortes, T. M., Foy, C. M., Dinkla, L., Reyes San Martin, F., Ard, J. D., Serra, M. C., & Beavers, D. P. (2025) · Obesity · doi:10.1002/oby.24172 · Cited by 41
“However, the relatively short study durations (i.e., 3 – 6 months; bone remodeling typically takes a minimum of 6 months) [45] and lack of sensitivity in whole-body BMD to change could also explain these findings.”
A theoretical analysis of the changes in basic multicellular unit activity at menopause
Hernandez, C. J., Beaupré, G. S., & Carter, D. R. P. (2003) · Bone · doi:10.1016/s8756-3282(03)00037-1 · Cited by 42
“Much shorter values for the secondary mineralization period based on estimates in the literature [39] have been used in previous computer models [8,15].”
BackgroundMethodHepatic Osteodystrophy Is Common in Patients with Noncholestatic Liver Disease
Choudhary, N. S., Tomar, M., Chawla, Y. K., Bhadada, S. K., Khandelwal, N. K., Dhiman, R. K., Duseja, A. K., & Bhansali, A. K. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1722-y · Cited by 36
“Bones continuously undergo a process of resorption and deposition; being broken down by osteoclasts and formed by osteoblasts [5].”
BackgroundWhat are the Dietary Requirements for Calcium and Vitamin D?
Prentice, A. (2002) · Calcified Tissue International · doi:10.1007/s00223-001-0035-0 · Cited by 36
“This effect is likely to represent a bone remodelling transient, in which a decrease in osteoclast activation frequency, caused by the step increase in Ca intake, results in a smaller bone remodelling space [17, 18 ].”
BackgroundTangestani, H., Djafarian, K., Emamat, H., Arabzadegan, N., & Shab‐Bidar, S. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1558172 · Cited by 35
Ward, K. A., Cole, T. J., Laskey, M. A., Ceesay, M., Mendy, M., Sawo, Y., & Prentice, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1150 · Cited by 35
Buenzli, P. R., Pivonka, P., & Smith, D. W. (2013) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-013-0495-y · Cited by 38
“…on (i) the final balance of bone turned over by a BMU, i.e., the amount of bone refilled compared to the amount of bone resorbed, and (ii) the number of active BMUs, due to the temporary BMU cavities that exist before refilling by the osteoblasts has completed (Heaney 1994; Hernandez et al. 2003).”
BackgroundMoghetti, P., Castello, R., Zamberlan, N., Rossini, M., Gatti, D., Negri, C., Tosi, F., Muggeo, M., & Adámi, S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5606 · Cited by 43
“In these two groups, GnRHa administration was associated with important increases in the biochemical indexes of bone turnover, and this is expected to be associated with expansion of the so-called remodeling space (23), which explains at least in part the observed BMD changes.”
BackgroundOn the Trabecular “Thickness”-Number Problem
Frost, H. M. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.11.1816 · Cited by 32
“Note, steady states cannot reveal the transients that caused them,((17,41,43,44)) just as being in Rome (a steady state) cannot tell how one arrived there (the transient, i.”
BackgroundGinty, F., Flynn, A., & Cashman, K. D. (1998) · British Journal Of Nutrition · doi:10.1017/s0007114598001500 · Cited by 33
“The suppression of bone resorption observed in the present study, if sustained, would be expected to result in suppression of the bone remodelling rate and a measurable increase in bone mass over time (Heaney, 1994).”
BackgroundUpdate on nutrients involved in maintaining healthy bone
Rondanelli, M., Opizzi, A., Perna, S., & Faliva, M. A. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.09.006 · Cited by 34
“The aforementioned duration of the intervention study has been established considering that the bone-remodeling cycle ranges from 30 to 80 weeks according to Heaney’s simulation model.(15) With respect to in vitro and animal models studies, the most significant studies that clearly explain the effects of specific nutr…”
A Review of Clinical Trials of Therapies for Osteoporosis Using Fracture as an End Point
Blank, R. D., & Bockman, R. S. (1999) · Journal of Clinical Densitometry · doi:10.1016/s1094-6950(06)60409-5 · Cited by 36
High intake of milk, but not meat, decreases bone turnover in prepubertal boys after 7 days
Budek, A. Z., Hoppe, C., Michaelsen, K. F., & Mølgaard, C. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602605 · Cited by 35
“It has been hypothesized that the calcium-related decline in bone turnover can be explained by bone remodeling transient (Heaney, 1994).”
BackgroundNutrition and Risk for Osteoporosis
Heaney, R. P. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50028-3 · Cited by 32
Self-citationSkeletal lead release during bone resorption: effect of bisphosphonate treatment in a pilot study.
Gulson, B. L., Mizon, K. J., Smith, H. C., Eisman, J. A., Palmer, J. M., Korsch, M. J., Donnelly, J., & Waite, K. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.021101017 · Cited by 30
Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss
Khosla, S., & Pacifici, R. (2013) · Osteoporosis · doi:10.1016/b978-0-12-415853-5.00046-7 · Cited by 31
Mulvihill, B. M., & Prendergast, P. J. (2010) · Clinical Biomechanics · doi:10.1016/j.clinbiomech.2010.01.006 · Cited by 35
“In previous computational studies it was found that increases in the activation frequency of BMUs and increases in the net bone deficit of a remodelling cycle lead to a gradual reduction in bone mass and deterioration in bone architecture (Ruimerman et al., 2005; van der Linden et al., 2001; Heaney, 1994).”
BackgroundMorabito, N., Gaudio, A., Lasco, A., Vergara, C., Tallarida, F., Crisafulli, G., Trifiletti, A., Cincotta, M., Pizzoleo, M. A., & Frisina, N. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1397-0 · Cited by 28
“This limitation is explained by the decrease in bone formation which follows the inhibition of bone resorption [6], and some studies actually show a residual decrease in bone turnover up to 2 years after discontinuation of alendronate [7].”
BackgroundInterpreting trials of bone-active agents
Heaney, R. P. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80309-x · Cited by 29
Self-citationChristen, P., Ito, K., Müller, R., Rubin, M. R., Dempster, D. W., Bilezikian, J. P., & van Rietbergen, B. (2012) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2012.06.031 · Cited by 28
“…in bone mass are the result of the strong suppression of bone turnover alone, since complete suppression of osteoclast activity would increase the bone mass by no more than 5% due to filling of the resorption space (Deng et al., 2005; Heaney, 1994; Khan, 2001; Van Der Linden et al., 2001).”
InfluentialValk, N. K., Erdtsieck, R. J., Algra, D., Lamberts, S. W. J., & Pols, H. A. P. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02038.x · Cited by 28
Qiu, S., Rao, D. S., Palnitkar, S., & PARFITT, A. M. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091003 · Cited by 28
“This contrasts with reversible bone loss owing to expansion of the remodeling space.((7)) During early rapid bone loss from the cancellous surface, some trabeculae are completely removed because of increased Rs.”
BackgroundIlich, J. Z., Brownbill, R. A., & Coster, D. C. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1412-z · Cited by 30
“It is possible that this supplementation suppressed bone turnover leading to bone remodeling transient (Heaney 1994) and caused a slight increase in measurable BMD.”
Abrahamsen, B., Hangaard, J., Horn, H. C., Hansen, T. B., Gregersen, G., Hansen‐Nord, M., Vahl, N., Junker, P., Andersen, M., & Hagen, C. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01582.x · Cited by 27
“Incidentally, this contrasts with antiresorptive treatments, where the increase in BMD is particularly pronounced in the first years of treatment due to reduced bone remodelling (Heaney, 1994, 1995).”
BackgroundRole of oral pamidronate in preventing bone loss in postmenopausal women
Lees, B., Garland, S. W., Walton, C., Ross, D., Whitehead, M., & Stevenson, J. C. (1996) · Osteoporosis International · doi:10.1007/bf01629581 · Cited by 26
“This plateau effect has been observed with other antiresorptive therapies such as hormone replacement therapy (HRT) and probably reflects the transient filling in of the resorption cavities already present when anti-resorptive therapy is instigated [ 12 ].”
BackgroundPhysiologically based mathematical model of transduction of mechanobiological signals by osteocytes
Hambli, R., & Rieger, R. (2011) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-011-0294-2 · Cited by 27
“and biological processes of bone were proposed by (Hart et al. 1984; Heaney 1994; Martin 1995).”
BackgroundMethodBeavers, K. M., Lynch, S. D., Fanning, J. T., Howard, M. J., Lawrence, E., Lenchik, L., Shapses, S. A., Weaver, A. A., Wherry, S. J., Zamora, Z., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.16772 · Cited by 27
Calcium requirements for Asian children and adolescents.
Lee, W. T. K., & Ji, J. (2008) · PubMed · Cited by 24
Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis
McClung, M. R. (1996) · Bone · doi:10.1016/s8756-3282(96)90165-9 · Cited by 24
Intermittent versus continuous clodronate administration in postmenopausal women with low bone mass
Filipponi, P., Cristallini, S., Policani, G., Schifini, M. F., Casciari, C., & Garinei, P. (2000) · Bone · doi:10.1016/s8756-3282(99)00273-2 · Cited by 24
Soybean and the Prevention of Chronic Human Disease
Birt, D. F., Hendrich, S., Alekel, D. L., & Anthony, M. S. (2004) · Agronomy monograph/Agronomy · doi:10.2134/agronmonogr16.3ed.c21 · Cited by 37
Miller, P. D. (1999) · Disease-a-Month · doi:10.1016/s0011-5029(99)90010-x · Cited by 34
Provocative relation between soy and bone maintenance
Erdman, J. W., Stillman, R. J., & Boileau, R. A. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.679 · Cited by 23
Bone mineral density in Nigerian children after discontinuation of calcium supplementation
Umaretiya, P. J., Thacher, T. D., Fischer, P. R., Cha, S. S., & Pettifor, J. M. (2013) · Bone · doi:10.1016/j.bone.2013.03.017 · Cited by 24
“Calcium may reduce activation of osteoclastic bone resorption, reduce bone turnover, and increase skeletal mineralization, leading to a temporary increase in bone density that does not persist [22].”
BackgroundThomas, T., Barou, O., Vico, L., Alexandre, C., & Lafage‐Proust, M. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.2.198 · Cited by 22
Diet-Induced Weight Loss: The Effect of Dietary Protein on Bone
Tang, M., O’Connor, L. E., & Campbell, W. W. (2013) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.08.021 · Cited by 25
Maximal strength training improves musculoskeletal health in amphetamine users in clinical treatment
Nygård, M., Mosti, M. P., Brose, L., Flemmen, G., Stunes, A. K., Sørskår-Venæs, A., Heggelund, J., & Wang, E. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4623-5 · Cited by 25
The remodeling transient and the calcium economy
Aloia, J. F., Talwar, S. A., Pollack, S. Z., & Yeh, J. K. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0542-6 · Cited by 21
“Heaney [3] calculated an 8% reduction in remodeling at year 1.”
BackgroundInfluentialMcClung, M. R. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000400018 · Cited by 32
On Changing Views about Age-Related Bone Loss
Frost, H. M. (2003) · Springer eBooks · doi:10.1007/978-1-4419-8891-1_2 · Cited by 19
Moghetti, P., Castello, R., Zamberlan, N., Rossini, M., Gatti, D., Negri, C., Tosi, F., Muggeo, M., & Adámi, S. (1999) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199909000-00020 · Cited by 21
Zhou, X., Sun, S., Chen, Y., Liu, C., Li, D., Cheng, Q., Cheng, Q., Li, Y., Xu, K., & Ta, D. (2023) · Ultrasonics · doi:10.1016/j.ultras.2023.106973 · Cited by 18
van der Linden, J. C., Verhaar, J. A. N., Pols, H. A. P., & Weinans, H. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-2151-x · Cited by 21
“Previously, other simulation models of bone remodeling during aging, menopause and antiresorptive treatment have been performed [13, 14, 16, 43–45].”
Leslie, W. D., Hans, D. B., & Silva, B. C. C. (2023) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2023.01.001 · Cited by 17
Wherry, S. J., Miller, R. M., Jeong, S. H., & Beavers, K. M. (2021) · Nutrients · doi:10.3390/nu13041250 · Cited by 19
“However, as bone remodeling typically requires a minimum of 4 to 6 months and can continue for at least 12 months [70], we focused on weight observations from the five trials lasting at least six months in duration when drawing conclusions from the available literature.”
BackgroundHeaney, R. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-961-5_10 · Cited by 16
“to reproduce the pubertal increase in BMD, and in recent years it has been customary to say that, apart from whatever remodeling transient estrogen/hormone replacement therapy (ERT/HRT) may produce in postmenopausal women ( 32 ), the principal effect of ERT/ HRT on bone is stabilization of bone mass, rather than resto…”
BackgroundSelf-citationGaudio, A., Lasco, A., Morabito, N., Atteritano, M., Vergara, C., Catalano, A., Fries, W., Trifiletti, A., & Frisina, N. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347549 · Cited by 17
Osteoporosis Associated with Pregnancy
Wagman, R. B., & Marcus, R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00044-3 · Cited by 15
3 Growth hormone therapy and fracture risk in the growth hormone-deficient adult
Johannsson, G., & Ohlsson, C. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80029-3 · Cited by 14
A Risk-Benefit Assessment of Alendronate in the Treatment of Involutional Osteoporosis
Devogelaer, J. (1998) · Drug Safety · doi:10.2165/00002018-199819020-00005 · Cited by 14
“[80] The continued, albeit less marked, gains in BMD during the third treatment years suggest that long term therapy with alendronate may reverse the imbalance between bone resorption and bone formation observed in postmenopausal osteoporosis.”
BackgroundThe prevention and treatment of osteoporosis
Golden, B. D. (1998) · Arthritis & Rheumatism · doi:10.1002/art.1790110208 · Cited by 17
Lloyd, T., Rollings, N. J., & Chinchilli, V. M. (1998) · Springer eBooks · doi:10.1007/978-1-4612-2228-6_2 · Cited by 14
Quantification of remodeling parameter sensitivity—assessed by a computer simulation model
Thomsen, J. S., Mosekilde, L., & Mosekilde, E. (1996) · Bone · doi:10.1016/s8756-3282(96)00231-1 · Cited by 14
Biochemical Assessment Of Skeletal Activity
Blumsohn, A., Hannon, R. A., & Eastell, R. (1995) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/s1047-9651(18)30452-2 · Cited by 13
The volume of brisk walking is the key determinant of BMD improvement in premenopausal women
Lan, Y., & Feng, Y.-J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265250 · Cited by 16
“Some studies have noted that it can take 12 months, or longer in people with osteoporosis, of bone remodeling before a new steady state of bone metabolism can be reached [27].”
BackgroundDietary calcium and bone health in the elderly: uncertainties about recommendations
Anderson, J. J. B., & Sjöberg, H. E. (2001) · Nutrition Research · doi:10.1016/s0271-5317(00)00291-8 · Cited by 12
On the Evolution and Contemporary Roles of Bone Remodeling
Kostenuik, P. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00037-6 · Cited by 16
Elevated Microdamage Spatially Correlates with Stress in Metastatic Vertebrae
Atkins, A., Burke, M., Samiezadeh, S., Akens, M. K., Hardisty, M., & Whyne, C. M. (2019) · Annals of Biomedical Engineering · doi:10.1007/s10439-018-02188-8 · Cited by 16
Deluiz, D., Delcroix, G. J.-R., D’Ippolito, G., Grau-Monge, C., Bonnin-Marquez, A., Reiner, T., Tinoco, E. M. B., Amadeu, T. P., Pires, F. R., & Schiller, P. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-48236-8 · Cited by 11
van Schaick, E., Zheng, J., Ruixo, J. J. P., Gieschke, R., & Jacqmin, P. (2015) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-015-9423-3 · Cited by 14
Recovery of Decreased Bone Mineral Mass After Lower-Limb Fractures in Adolescents
Ceroni, D., Martin, X., Delhumeau, C., Farpour‐Lambert, N. J., Coulon, G. D., Dubois-Ferrière, V., & Rizzoli, R. (2013) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.l.00809 · Cited by 12
Design Considerations for Clinical Investigations of Osteoporosis
Heaney, R. P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00075-3 · Cited by 11
Self-citationHutson, M. J., O'Donnell, E., Brooke‐Wavell, K., James, L. J., Raleigh, C. J., Carson, B. P., Sale, C., & Blagrove, R. C. (2023) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.14437 · Cited by 10
Castoldi, N. M., Pickering, E., Sansalone, V., Cooper, D. M. L., & Pivonka, P. (2024) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-023-01812-4 · Cited by 11
“Based on the works of Martin (1984, 1991); Heaney (1994), this remodelling model of the trabecular bone is discrete both in space and time, but differently than previous discrete models, we include every phase of the remodelling process, from resorption to mineralisation.”
MethodBisphosphonates: Mechanisms of Action and Role in Osteoporosis Therapy
Santora, A. C., & Sharma, A. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_14 · Cited by 13
Estrogen deficiency and the pathogenesis of osteoporosis
Khosla, S., & Pacifici, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00032-0 · Cited by 20
Injectable bisphosphonates in the treatment of postmenopausal osteoporosis
Sartori, L., Adami, S., Filipponi, P., & Crepaldi, G. (2003) · Aging Clinical and Experimental Research · doi:10.1007/bf03324509 · Cited by 10
Zamberlan, N., Castello, R., Gatti, D., Rossini, M., Braga, V., Fracassi, E., & Adámi, S. (1997) · Osteoporosis International · doi:10.1007/bf01623688 · Cited by 10
Bone Remodeling Findings in Osteoporosis
Recker, R. R., & Barger-Lux, M. J. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50040-4 · Cited by 10
Metadata
- Authors
- Heaney, R. P.
- Affiliations
- Creighton University (US)
- Corresponding author
- Heaney, Robert P.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-10-01
- Volume
- 9
- Issue
- 10
- Pages
- 1515-1523
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2075992155
- Cited by
- 286
- References
- 19
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 8 · 2022: 5 · 2021: 2 · 2020: 6 · 2019: 7 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 3 · 2014: 5 · 2013: 13 · 2012: 7
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Creighton Digital Repository (CDR) (submittedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- bone remodeling, bone mineral density, osteoporosis treatment, histomorphometry, computer simulation, bone loss
- MeSH terms
- Algorithms, Calcium, Computer Simulation, Female, Humans, Models, Biological, Reference Values, Bone Density, Osteoporosis, Postmenopausal, Bone Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.